Consensus Perrigo Company plc

Stocks

PRGO

IE00BGH1M568

Pharmaceuticals

Real-time Estimate Cboe BZX 09:57:10 2026-09-30 EDT			5-day change	1st Jan Change
14.94 ^USD	-0.37%		+9.03%	+8.41%

08-05	Perrigo Company plc, Q2 2026 Earnings Call, Aug 05, 2026
08-05	Perrigo Shares Rise After Fiscal Q2 Adjusted Earnings, Net Sales Beat Estimates	MT

Evolution of the Average Target: Perrigo Company plc

Evolution of the Target Price: Perrigo Company plc

Changes in Analyst Recommendations: Perrigo Company plc

5cfcb103d113ab5c4af90a7689f45dec.n58ofFm-8yyKBzhwo4zXHkXHzr6CloHV_AbXuibSRZU.68YQL2zulR_-Smwo1P2cMy60q87BpMfitD7h9RG4L9Dr5XgvbIyRW_BYVw~387e3e47896f1c2991cf422ee52b47f6

Analysts' recommendations: Perrigo Company plc

11-06	Perrigo Shares Fall After JPMorgan Downgrade	MT
11-06	JPMorgan Downgrades Perrigo to Neutral From Overweight, Adjusts Price Target to $20 From $32	MT
11-05	(PRGO) Perrigo Expects Full Year 2025 Adjusted EPS Range $2.70 - $2.80, vs. FactSet Est of $2.97	MT
25-01-06	Piper Sandler Downgrades Perrigo to Neutral From Overweight, Lowers Price Target to $27 From $34	MT
24-07-11	Piper Sandler Trims Price Target on Perrigo to $35 From $36, Maintains Overweight Rating	MT
24-06-13	Piper Sandler Adjusts Price Target on Perrigo to $36 From $39, Maintains Overweight Rating	MT
24-04-08	Piper Sandler Raises Perrigo's Price Target to $39 From $35, Maintains Overweight Rating	MT
24-02-28	JPMorgan Cuts Price Target on Perrigo to $41 From $48, Maintains Overweight Rating	MT
23-03-07	Canaccord Genuity Starts Perrigo at Buy With $49 Price Target	MT
23-03-06	Raymond James Adjusts Perrigo Price Target to $43 From $42, Maintains Outperform Rating	MT
22-11-09	Raymond James Adjusts Price Target on Perrigo Company to $42 From $48, Maintains Outperform Rating	MT
22-09-14	Argus Upgrades Perrigo to Buy From Hold; Price Target is $46	MT
22-09-06	Wells Fargo Raises Perrigo to Overweight From Equalweight, Price Target to $54 From $48	MT
22-05-04	Raymond James Adjusts Perrigo's Price Target to $48 from $55, Keeps Outperform Rating	MT
21-11-11	Raymond James Adjusts Price Target on Perrigo to $55 From $59, Maintains Outperform Rating	MT
21-10-14	Perrigo : Raymond James Upgrades Perrigo to Outperform from Market Perform, Sets $59 Price Target	MT
21-09-30	Perrigo : Jefferies Upgrades Perrigo to Buy from Hold, Adjusts PT to $63 from $45	MT
21-09-30	Perrigo : Jefferies Upgrades Perrigo to Buy from Hold, Adjusts Price Target to $63 from $45	MT
21-08-12	Perrigo : RBC Cuts Price Target on Perrigo to $48 From $51 After Q2 Results Miss Expectations; Sector Perform Rating Maintained	MT
21-03-05	Perrigo : Morgan Stanley Adjusts Perrigo Company PT to $45 From $53, Maintains Equal Weight Rating	MT
21-03-02	Perrigo : RBC Capital Adjusts Perrigo's Price Target to $51 From $49, Maintains Sector Perform Rating	MT
21-01-06	Perrigo : RBC Capital Downgrades Perrigo Company to Sector Perform From Outperform, Adjusts PT to $49 From $59	MT

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	PERRIGO COMPANY PLC					+10%
	ELI LILLY AND COMPANY					+12.17%
	JOHNSON & JOHNSON					+4.37%
	ABBVIE INC.					+5.91%
	MERCK & CO., INC.					+4.29%
	ROCHE HOLDING AG					+7.46%
	NOVARTIS AG					+5.11%
	ASTRAZENECA PLC					+28.35%
	AMGEN INC.					-7.72%
	GILEAD SCIENCES, INC.					+4.87%
	Average					+7.48%
	Weighted average by Cap.					+7.93%